Approvals/NMPA/Recombinant Ebola Virus Disease Vaccine (Adenovirus Type 5 Vector)

Approved

生物制品

Recombinant Ebola Virus Disease Vaccine (Adenovirus Type 5 Vector)

康希诺生物股份公司🇨🇳 National Medical Products Administration

Approval Id: 7Leafjd9Kdo
Approval Number: 国药准字S20170008
Generic Name: 重组埃博拉病毒病疫苗(腺病毒载体)
Generic Name En: Recombinant Ebola Virus Disease Vaccine (Adenovirus Type 5 Vector)
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 复溶后每瓶0.5ml，每1次人用剂量2瓶，共1ml，含表达埃博拉病毒包膜糖蛋白的重组复制缺陷型人5型腺病毒8×10^10VP。
Reg Date: 2022-10-13
Company Name: 康希诺生物股份公司
Company Address: 天津经济技术开发区西区南大街185号西区生物医药园四层401-420号
Production Company Name: 康希诺生物股份公司
Production Company Address: 天津经济技术开发区西区南大街185号西区生物医药园三层
Company Detail Path: /organization/cansino-biologics-inc
Production Company Detail Path: /organization/cansino-biologics-inc

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 13, 2022

Approval ID

7Leafjd9Kdo

Type

生物制品